New individualized aflibercept treatment protocol for branch retinal vein occlusion with macular edema

We evaluated the long-term (24-month) efficacy of a novel individualized treatment protocol with 2 mg aflibercept for treatment-naive BRVO with macular edema. Each patient received an initial aflibercept injection and was then examined every 2 weeks until recurrence of edema. At recurrence, each pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Noma, Hidetaka, Yasuda, Kanako, Narimatsu, Akitomo, Asakage, Masaki, Shimura, Masahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883511/
https://www.ncbi.nlm.nih.gov/pubmed/36707696
http://dx.doi.org/10.1038/s41598-023-28533-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883511/
https://www.ncbi.nlm.nih.gov/pubmed/36707696
http://dx.doi.org/10.1038/s41598-023-28533-z

Ejemplares similares